NovoCure Ltd. (NVCR) PT Lowered to $40 at Wells Fargo
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $15.83 -0.06%
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Join SI Premium – FREE
Wells Fargo analyst Larry Biegelsen lowered the price target on NovoCure Ltd. (NASDAQ: NVCR) to $40.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Vertex (VRTX) PT Raised to $615 at UBS
- Constellation Brands (STZ) PT Lowered to $180 at Bernstein SocGen Group
- Adicet Bio Inc. (ACET) PT Raised to $28 at Wedbush
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
